Literature DB >> 23431210

Adherence to behavioral interventions for stress incontinence: rates, barriers, and predictors.

Diane Borello-France1, Kathryn L Burgio, Patricia S Goode, Wen Ye, Alison C Weidner, Emily S Lukacz, John-Eric Jelovsek, Catherine S Bradley, Joseph Schaffer, Yvonne Hsu, Kimberly Kenton, Cathie Spino.   

Abstract

BACKGROUND: First-line conservative treatment for stress urinary incontinence (SUI) in women is behavioral intervention, including pelvic-floor muscle (PFM) exercise and bladder control strategies.
OBJECTIVE: The purposes of this study were: (1) to describe adherence and barriers to exercise and bladder control strategy adherence and (2) to identify predictors of exercise adherence.
DESIGN: This study was a planned secondary analysis of data from a multisite, randomized trial comparing intravaginal continence pessary, multicomponent behavioral therapy, and combined therapy in women with stress-predominant urinary incontinence (UI).
METHODS: Data were analyzed from the groups who received behavioral intervention alone (n=146) or combined with continence pessary therapy (n=150). Adherence was measured during supervised treatment and at 3, 6, and 12 months post-randomization. Barriers to adherence were surveyed during treatment and at the 3-month time point. Regression analyses were performed to identify predictors of exercise adherence during supervised treatment and at the 3- and 12-month time points.
RESULTS: During supervised treatment, ≥86% of the women exercised ≥5 days a week, and ≥80% performed at least 30 contractions on days they exercised. At 3, 6, and 12 months post-randomization, 95%, 88%, and 80% of women, respectively, indicated they were still performing PFM exercises. During supervised treatment and at 3 months post-randomization, ≥87% of the women reported using learned bladder control strategies to prevent SUI. In addition, the majority endorsed at least one barrier to PFM exercise, most commonly "trouble remembering to do exercises." Predictors of exercise adherence changed over time. During supervised intervention, less frequent baseline UI and higher baseline 36-Item Short-Form Health Survey (SF-36) mental scores predicted exercise adherence. At 3 months post-randomization, women who dropped out of the study had weaker PFMs at baseline. At 12 months post-randomization, only "trouble remembering" was associated with exercise adherence. LIMITATIONS: Adherence and barrier questionnaires were not validated.
CONCLUSIONS: Adherence to PFM exercises and bladder control strategies for SUI can be high and sustained over time. However, behavioral interventions to help women link exercise to environmental and behavioral cues may only be beneficial over the short term.

Entities:  

Mesh:

Year:  2013        PMID: 23431210      PMCID: PMC3664038          DOI: 10.2522/ptj.20120072

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  45 in total

1.  Exercise adherence following physical therapy intervention in older adults with impaired balance.

Authors:  Rebecca Forkan; Breeanna Pumper; Nicole Smyth; Hilary Wirkkala; Marcia A Ciol; Anne Shumway-Cook
Journal:  Phys Ther       Date:  2006-03

2.  Adherence to a behavioral program to prevent incontinence.

Authors:  Sandra H Hines; Julia S Seng; Kassandra L Messer; T E Raghunathan; Ananias C Diokno; Carolyn M Sampselle
Journal:  West J Nurs Res       Date:  2007-02       Impact factor: 1.967

3.  Incontinence improves in older women after intensive pelvic floor muscle training: an assessor-blinded randomized controlled trial.

Authors:  Margaret Sherburn; Margaret Bird; Marcus Carey; Kari Bø; Mary P Galea
Journal:  Neurourol Urodyn       Date:  2011-01-31       Impact factor: 2.696

4.  Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial.

Authors:  K L Burgio; J L Locher; P S Goode; J M Hardin; B J McDowell; M Dombrowski; D Candib
Journal:  JAMA       Date:  1998-12-16       Impact factor: 56.272

5.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

6.  Factors impacting self-care for urinary incontinence.

Authors:  Jill L Milne; Katherine N Moore
Journal:  Urol Nurs       Date:  2006-02

7.  Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years.

Authors:  Kari Bø; Bernt Kvarstein; Ingrid Nygaard
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

8.  Non-surgical management of stress urinary incontinence: ambulatory treatments for leakage associated with stress (ATLAS) trial.

Authors:  Holly E Richter; Kathryn L Burgio; Patricia S Goode; Diane Borello-France; Catherine S Bradley; Linda Brubaker; Victoria L Handa; Paul M Fine; Anthony G Visco; Halina M Zyczynski; John T Wei; Anne M Weber
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

9.  Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings.

Authors:  Kathryn L Burgio; Patricia S Goode; Holly E Richter; Julie L Locher; David L Roth
Journal:  Neurourol Urodyn       Date:  2006       Impact factor: 2.696

10.  Which women do pelvic floor muscle exercises six months' postpartum?

Authors:  Kari Bø; Katrine Mari Owe; Wenche Nystad
Journal:  Am J Obstet Gynecol       Date:  2007-07       Impact factor: 8.661

View more
  13 in total

Review 1.  Pelvic Floor Muscle Training: Underutilization in the USA.

Authors:  Eliza Lamin; Lisa M Parrillo; Diane K Newman; Ariana L Smith
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

2.  Structured behavioral treatment research protocol for women with mixed urinary incontinence and overactive bladder symptoms.

Authors:  Diane K Newman; Diane Borello-France; Vivian W Sung
Journal:  Neurourol Urodyn       Date:  2017-05-02       Impact factor: 2.696

3.  A group-based yoga program for urinary incontinence in ambulatory women: feasibility, tolerability, and change in incontinence frequency over 3 months in a single-center randomized trial.

Authors:  Alison J Huang; Margaret Chesney; Nadra Lisha; Eric Vittinghoff; Michael Schembri; Sarah Pawlowsky; Amy Hsu; Leslee Subak
Journal:  Am J Obstet Gynecol       Date:  2018-10-26       Impact factor: 8.661

4.  Continence: Bowel and Bladder and Physical Function Decline in Women.

Authors:  Daisy Hassani; Lily Arya; Uduak Andy
Journal:  Curr Geriatr Rep       Date:  2020-03-09

5.  Internet-based treatment of stress urinary incontinence: 1- and 2-year results of a randomized controlled trial with a focus on pelvic floor muscle training.

Authors:  Malin Sjöström; Göran Umefjord; Hans Stenlund; Per Carlbring; Gerhard Andersson; Eva Samuelsson
Journal:  BJU Int       Date:  2015-06-03       Impact factor: 5.588

6.  Treatment of stress urinary incontinence with a mobile app: factors associated with success.

Authors:  Emma Nyström; Ina Asklund; Malin Sjöström; Hans Stenlund; Eva Samuelsson
Journal:  Int Urogynecol J       Date:  2017-12-08       Impact factor: 2.894

7.  User Experience of an App-Based Treatment for Stress Urinary Incontinence: Qualitative Interview Study.

Authors:  Ina Asklund; Eva Samuelsson; Katarina Hamberg; Göran Umefjord; Malin Sjöström
Journal:  J Med Internet Res       Date:  2019-03-14       Impact factor: 5.428

8.  Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study.

Authors:  Pontus Rygh; Ina Asklund; Eva Samuelsson
Journal:  BMJ Open       Date:  2021-01-04       Impact factor: 2.692

Review 9.  Pessary use in stress urinary incontinence: a review of advantages, complications, patient satisfaction, and quality of life.

Authors:  Ghadeer Al-Shaikh; Sadiqa Syed; Somaia Osman; Abdulrahman Bogis; Ahmed Al-Badr
Journal:  Int J Womens Health       Date:  2018-04-17

10.  Anxiety and depression in women with urinary incontinence using E-health.

Authors:  Nils Hansson Vikström; Elisabet Wasteson; Anna Lindam; Eva Samuelsson
Journal:  Int Urogynecol J       Date:  2020-02-24       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.